[Lowering of the lipoproteins in type IIa hyperlipoproteinemia by means of bezafibrate. Comparison with clofibrate].
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood
D000924:Anticholesteremic Agents; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D002784:Cholesterol; D002994:Clofibrate
Lipoproteinsenkung durch Bezafibrat bei Hyperlipoproteinämie Typ IIa. Vergleich mit Clofibrat.